ScreenerHero

SNGX Soligenix, Inc.

NAS · US · Healthcare · Biotechnology · soligenix.com
0.3535USD-1.26%Mkt Cap: 7.69M $P/E: —

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized Bi…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap7.69M USD
Enterprise Value-1.72M USD
Revenue (TTM)—
Gross Profit0 USD
Net Income (TTM)-11.08M USD
Revenue/Share—
Last Price0.3535 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees13
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.43
PEG—
EV/EBITDA0.16
EV/Revenue—
P/S—
P/B1.17
EPS (TTM)-0.78
EPS (Forward)-0.25
52W Range
0.28004% of range2.000
52W High2.000 USD
52W Low0.2800 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.37%
ROA-119.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-10.27M USD
CapEx (TTM)5.88K USD
FCF Margin—
FCF Yield-81.64%
Net Debt-9.51M USD
Net Debt/EBITDA0.86
Balance Sheet
Debt/Equity0.07
Current Ratio2.77
Quick Ratio2.67
Book Value/Sh0.31 USD
Cash/Share0.45 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay DateOct 7, 2016
Splits
Last Split1:16
Split DateJun 6, 2024
Analyst Consensus
Rating—
Target (Mean)1.375 USD
Upside (mean)+289.0%
Target Range1.250 USD – 1.500 USD
1.250+289.0% to mean1.500
# Analysts2
Ownership
Shares Out.21.77M
Float21.66M
Insiders4.59%
Institutions6.72%
Short Interest
Short Ratio0.9d
Short % Float0.93%
Short % Out.0.93%
Shares Short202.56K
Short (prev mo.)207.64K
Technical
SMA 500.3778 (-6.4%)
SMA 2000.7732 (-54.3%)
Beta2.00
S&P 52W Chg16.45%
Avg Vol (30d)206.74K
Avg Vol (10d)179.12K
Technical Indicators
RSI (14)37.5
MACD-0.0059
MACD Signal-0.0043
MACD Hist.-0.0016
BB Upper0.3904 USD
BB Middle0.3692 USD
BB Lower0.3480 USD
BB Width11.49%
ATR (14)0.0136 USD
Vol Ratio (20d)0.37x